ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CCEL vs MGRX // RETURN ON INVESTED CAPITAL (ROIC)

Cryo-Cell International Inc. (NYSE) VS. Mangoceuticals Inc. (NASDAQ) • 15-METRIC TALLY: CCEL 4 — MGRX 0
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CCEL
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CCEL VS. MGRX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CCEL MGRX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 54.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE 18.20% -35.00% +53.20 CCEL /roic <GO>
EV/EBITDA & P/E Valuation 61.2x — — TIE /valuation <GO>
Free Cash Flow Yield 12.55% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -26.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 7.73% 0.00% +7.73 CCEL /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 64.3 32.1 +32.22 CCEL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $41.8M $5.7M $36.2M CCEL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CCEL REV MGRX REV CCEL GROSS % MGRX GROSS % CCEL FCF MGRX FCF
FY 2025 $0 $456.0K — 54.9% $5.2M -$5.9M
FY 2024 $0 $615.9K — 61.7% $3.6M -$4.9M
FY 2023 $0 $731.5K — — $8.9M -$7.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CCEL // BETA —
MGRX // BETA —